These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25510178)

  • 1. MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.
    Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):127-33. PubMed ID: 25510178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.
    Zhang Y; Zhong Q; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
    Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
    Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
    Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
    Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
    Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
    Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic accuracy of fine needle aspiration biopsy for detection of malignancy in pediatric thyroid nodules: protocol for a systematic review and meta-analysis.
    Lai SW; Roberts DJ; Rabi DM; Winston KY
    Syst Rev; 2015 Sep; 4():120. PubMed ID: 26399232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
    Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
    J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs.
    Kitano M; Rahbari R; Patterson EE; Xiong Y; Prasad NB; Wang Y; Zeiger MA; Kebebew E
    Ann Surg Oncol; 2011 Nov; 18(12):3443-52. PubMed ID: 21553140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
    Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
    Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
    Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
    Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ECM1 and MMP-2 in follicular thyroid lesions among Egyptians.
    Abdel Salam R; El-Badry N; Rizk A; El-Sedfy A; Kamel N; El-Abd E
    Cancer Biomark; 2015; 15(4):441-58. PubMed ID: 25812648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-221/222 in thyroid cancer: A meta-analysis.
    Liang L; Zheng X; Hu M; Cui Y; Zhong Q; Wang S; Huang F
    Clin Chim Acta; 2018 Sep; 484():284-292. PubMed ID: 29894779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; McMillan A
    Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
    Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
    Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of miRNA in diagnosing thyroid cancer: a systematic review.
    Lodewijk L; Prins AM; Kist JW; Valk GD; Kranenburg O; Rinkes IH; Vriens MR
    Cancer Biomark; 2012; 11(6):229-38. PubMed ID: 23248180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.